China Resources Pharmaceutical Group Limited (FRA:640)

FRA:640 Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,593	4,453	3,733	4,765	2,515	2,636
Market Cap Growth	19.30%	19.30%	-21.66%	89.46%	-4.61%	-49.28%
Enterprise Value	14,378	16,724	14,550	15,344	11,756	9,818
Last Close Price	0.56	0.67	0.55	0.70	0.32	0.34
PE Ratio	8.15	10.10	7.59	10.03	5.92	7.58
PS Ratio	0.11	0.13	0.12	0.16	0.09	0.13
PB Ratio	0.28	0.34	0.32	0.44	0.24	0.31
P/TBV Ratio	1.43	1.78	1.63	2.09	1.20	1.27
P/FCF Ratio	1.82	2.26	2.25	4.11	2.14	3.83
P/OCF Ratio	1.55	1.92	1.88	3.25	1.74	3.05
EV/Sales Ratio	0.48	0.49	0.47	0.52	0.44	0.47
EV/EBITDA Ratio	7.91	8.64	8.40	9.68	8.73	8.40
EV/EBIT Ratio	10.06	10.55	10.34	11.61	10.59	9.98
EV/FCF Ratio	7.30	8.49	8.75	13.24	10.00	14.24
Debt / Equity Ratio	0.70	0.70	0.67	0.70	0.72	0.69
Debt / EBITDA Ratio	4.50	4.50	4.38	4.59	5.37	4.69
Debt / FCF Ratio	4.63	4.63	4.77	6.61	6.52	8.44
Asset Turnover	1.02	1.02	1.06	1.00	1.03	1.00
Inventory Turnover	6.30	6.30	7.07	6.99	7.42	7.17
Quick Ratio	1.03	1.03	1.00	0.94	0.95	0.92
Current Ratio	1.41	1.41	1.33	1.25	1.25	1.20
Return on Equity (ROE)	8.80%	8.80%	8.96%	8.09%	7.60%	7.12%
Return on Assets (ROA)	2.97%	2.97%	2.98%	2.80%	2.69%	2.92%
Return on Capital (ROIC)	4.65%	4.65%	4.72%	4.33%	4.13%	4.50%
Return on Capital Employed (ROCE)	9.50%	9.50%	9.80%	10.40%	9.20%	10.80%
Earnings Yield	12.27%	9.96%	13.18%	9.97%	16.90%	13.19%
FCF Yield	54.84%	44.25%	44.53%	24.32%	46.76%	26.14%
Dividend Yield	3.01%	2.68%	3.60%	2.76%	5.26%	3.68%
Payout Ratio	44.44%	44.44%	22.83%	23.23%	20.00%	20.96%
Buyback Yield / Dilution	-	-	-	-	0.01%	0.02%
Total Shareholder Return	3.01%	2.68%	3.60%	2.76%	5.27%	3.70%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.